Ipratropium-d7 bromide is the deuterium-labeled form of Ipratropium bromide. Ipratropium bromide (Sch 1000) acts as a muscarinic receptor antagonist, with IC50 binding values of 2.9 nM for M1 receptors, 2 nM for M2 receptors, and 1.7 nM for M3 receptors. It is suitable for use in research related to COPD (chronic obstructive pulmonary disease) and asthma.
- This compound can be used as a tracer.
- It can serve as an internal standard for quantitative analysis through techniques such as NMR, GC-MS, or LC-MS.
- Stable heavy isotopes, including hydrogen, carbon, and other elements, have been integrated into drug molecules primarily for quantitation as tracers during drug development.
- Deuteration is recognized for its potential to influence the pharmacokinetic and metabolic profiles of drugs.